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Abstract
Background: Overweight and obesity pose a big challenge to pregnancy as they are associated with adverse
maternal and perinatal outcome. Evidence of lifestyle intervention resulting in improved pregnancy outcome is
conflicting. Hence the objective of this study is to determine the efficacy of antenatal dietary, activity, behaviour or
lifestyle interventions in overweight and obese pregnant women to improve maternal and perinatal outcomes.
Methods: A systematic review and meta-analyses of randomised and non-randomised clinical trials following prior
registration (CRD420111122 http://www.crd.york.ac.uk/PROSPERO) and PRISMA guidelines was employed. A search of
the Cochrane Library, EMBASE, MEDLINE, CINAHL, Maternity and Infant care and eight other databases for studies
published prior to January 2012 was undertaken. Electronic literature searches, study selection, methodology and
quality appraisal were performed independently by two authors. Methodological quality of the studies was assessed
according to Cochrane risk of bias tool. All appropriate randomised and non-randomised clinical trials were included
while exclusions consisted of interventions in pregnant women who were not overweight or obese, had pre-existing
diabetes or polycystic ovarian syndrome, and systematic reviews. Maternal outcome measures, including maternal
gestational weight gain, gestational diabetes and Caesarean section, were documented. Fetal outcomes, including
large for gestational age and macrosomia (birth weight > 4 kg), were also documented.
Results: Thirteen randomised and six non-randomised clinical trials were identified and included in the meta-
analysis. The evidence suggests antenatal dietary and lifestyle intervention in obese pregnant women reduces
maternal pregnancy weight gain (10 randomised clinical trials; n = 1228; -2.21 kg (95% confidence interval -2.86 kg
to -1.59 kg)) and a trend towards a reduction in the prevalence of gestational diabetes (six randomised clinical
trials; n = 1,011; odds ratio 0.80 (95% confidence interval 0.58 to 1.10)). There were no clear differences reported for
other outcomes such as Caesarean delivery, large for gestational age, birth weight or macrosomia. All available
studies were assessed to be of low to medium quality.
Conclusion: Antenatal lifestyle intervention is associated with restricted gestational weight gain and a trend
towards a reduced prevalence of gestational diabetes in the overweight and obese population. These findings
need to be interpreted with caution as the available studies were of poor to medium quality.
Background
Both developed and developing countries are experien-
cing a rapid increase in the prevalence of obesity [1-3].
In the UK, 24% of women of reproductive age are now
obese (body mass index (BMI) equal or greater than
30 kg/m2) and the prevalence appears to be increasing
[4]. Studies in UK women show that the rates of obesity
in pregnancy have almost doubled in the last two dec-
ades [5,6]. Recent estimates suggest the prevalence of
obesity in pregnancy in the UK is at least 20% with 5%
having severe or morbid obesity [7,8].
Observational study data has linked obesity in preg-
nancy with adverse maternal and infant outcomes
[7-10]. Obesity increases the risks of gestational diabetes
[8,10-12], hypertensive disease (including pre-eclampsia)
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[8,13,14], thromboembolism [15,16], infection [14,17],
Caesarean section [8,18], congenital fetal anomalies [19],
macrosomia [13], induction [20], stillbirth [12], shoulder
dystocia [14] and preterm delivery [21]. Moreover,
maternal obesity may impact on long-term outcomes
such as the increasing weight of the child in infancy
and the severity of obesity in future generations
[10,22,23].
As most of the adverse outcomes of obese pregnancies
show strong associations with pre-pregnancy BMI, it is
reasonable to assume that the ideal intervention would
be to reduce obesity prior to pregnancy [24]. However,
this is difficult to achieve because 50% of pregnancies in
the UK are unplanned and a recent study concluded
that only a small proportion of women planning preg-
nancy follow nutrition and lifestyle recommendations
[25]. As such, an intervention pre-pregnancy may reach
only a small proportion of the intended women.
Alternatively, pregnancy itself may represent an ideal
opportunity to target lifestyle change as women have
increased motivation to maximise their own health and
that of their unborn child [25]. However, evidence of
benefit from published intervention studies appears lim-
ited and inconsistent [26-44]. We therefore sought to
determine the efficacy of combined dietary activity and
behaviour support interventions in overweight and
obese pregnant women by undertaking a systematic
review and meta-analysis according to PRISMA (Trans-
parent Reporting of Systematic Reviews and Meta-ana-
lyses) criteria for maternal clinical outcomes of weight
gain, gestational diabetes and Caesarean section and
infant outcomes, such as large for gestational age and
macrosomia. Our aim was to generate data of the high-
est statistical power and sensitivity. Hence, in compari-
son with previous similar themed systematic reviews
[45-48], we chose to interrogate multiple databases (not
restricted to English) and also separately meta-analyse
randomised clinical trials (RCTs) and non-RCTs evalu-
ating relevant clinical outcomes, including gestational
diabetes and Caesarean section, which had not been
attempted in prior meta-analyses.
Methods
Eligibility criteria
The eligible studies included RCTs and non-RCTs that
evaluated antenatal dietary and lifestyle interventions in
obese and overweight pregnant women whose outcome
measures included quantitative maternal and fetal health
outcomes. Systematic reviews and trials of women with
existing gestational diabetes, or trials of pre-conception
or postpartum interventions, were not included. Inclu-
sion of trials was not restricted by language, publication
date or country. Systematic reviews and observational
studies were excluded.
Information sources
Literature searches were performed using five mainstream
electronic databases (Cochrane Library, MEDLINE,
EMBASE, CINAHL, Maternity and Infant care), and eight
other databases (PsyclINFO via OVID SP, PyscLNFO via
OVID SP, Science Citation Index via Web of Science,
Social Science Citation Index via Web of Science, Global
Health, Popline, Medcarib, Nutrition database).
Search strategy
The following MeSH terms, words and combinations of
words, were used in constructing the systematic search:
overweight OR obesity; pregnancy OR pregnancy com-
plications OR pregnancy outcome OR prenatal care,
prenatal, antenatal, intervention, randomised controlled
trial, life style, “early intervention (education)”, health
education, education, patient education handout, patient
education, exercise, exercise therapy, health promotion,
diet, carbohydrate-restricted, diet, fat-restricted, diet,
reducing, diet therapy, weight loss. Full details of the
search strategy are shown in Table 1. The searches were
unlimited by time up to January 2012 and limited to
human studies and clinical trials. The systematic search
was undertaken in the mainstream databases and tar-
geted searches were conducted in the other databases.
Study selection
Electronic literature searches, study selection, methodol-
ogy, appropriateness for inclusion and quality appraisal
were performed independently and in duplicate by two
authors (E-ON and RV). Disagreements between
reviewers were resolved by consensus. Included studies
were divided into two groups (RCTs and non-RCTs)
and separately meta-analysed.
Data collection process
Two independent reviewers extracted the data. As a first
step, each paper was screened using the title and the
abstract. In the next round, studies were assessed for meth-
odological quality and appropriateness for inclusion by two
reviewers working independently from the full text of the
manuscript. This was done without consideration of the
results.
Data items
For each included trial, data was extracted on maternal
gestational weight gain; gestational diabetes; Caesarean
section; large for gestational age baby (> 4 kg); and birth
weight. The included studies have been summarised in
Tables 2 and 3.
Risk of bias in individual studies
The quality of studies was assessed based on how the
studies had minimised bias and error in their methods.
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We categorised the studies according to criteria based
on PRISMA guidelines [49] and the Cochrane Library
[50]. For example, high quality trials reported study
aims; control comparison similar to the intervention
group; relevant population demographics pre- and post-
intervention; and data on each outcome. These study
characteristics are tabulated in Tables 4 and 5. A final
assessment categorised the studies as high, medium or
low quality.
Summary and analysis of studies that meet the criteria
This is shown in Figure 1 and in a tabulated format
contained within Table 2 and 3.
Summary measures and data synthesis
The main measure of effect of the meta-analysis was the
odds ratio or standardised mean difference. The data
syntheses were conducted according to the Cochrane
methodology [50]. First, we used statistical meta-analysis
techniques to assess the efficacy of the interventions of
controlled trials. Chi-square statistics tests were used to
test for heterogeneity (Q statistics) between controlled
trials. When there was no significant heterogeneity, we
combined effect sizes in a fixed effect statistical meta-ana-
lysis using Review Manager (RevMan; Version 5.0,
Copenhagen: The Nordic Cochrane Centre, The Cochrane
Collaboration, 2008). The meta-analyses were performed
by calculating the odds ratios (for proportion data) or
standardised mean differences (for scale data) using a
fixed effects model. Quantitative analysis was performed
on an intention-to-treat basis focused on data derived
from the period of follow-up. There was heterogeneity
between studies because of the smaller sample size of
some of the studies (poor quality), variation of the study
population and the intensity and duration of the interven-
tional strategies being evaluated. A random effects model
was used to adjust for heterogeneity.
Results
Study characteristics
The review process is outlined in Figure 1 and the
selected papers summarised in Tables 2 and 3.
Fifteen trials met the inclusion criteria: 13 RCTs
[26-34] and six non-RCTs [35,36,38,39,51,52]. All 19
trials were performed in developed countries: five in the
USA, three in Canada, three in Australia, two in Finland
and one in Denmark, Netherlands, Sweden, Spain, Brazil
and Belgium (Tables 2 and 3). Five RCTs were judged
to be of medium quality [27,29,34]. The rest were
deemed low quality (Tables 4 and 5).
Table 1 Search strategy utilised for MEDLINE 1946 to January 2012
Batch Search term (MESH) Combination Result
1 Pregnancy Complications/OR Pregnancy/OR Pregnancy
Outcome/OR Pregnancy, High Risk/
646,055
2 Prenatal Care/OR Pregnancy/OR Pregnancy Complications 647,726
3 Antenatal.mp. 18,393
4 Gestation intervention.mp. 4
5 1 OR 2 OR 3 OR 4 651,321
6 Overweight.mp. OR Obesity/OR Overweight/OR Body Weight/ 249,097
7 Obesity/OR Obesity, Morbid/or Obesity.mp. 145,882
8 Body Weight/OR Obesity/OR Body Mass Index/or BMI.mp. OR
Overweight/
293,584
9 6 OR 7 OR 8 328,089
10 5 AND 9 21,583
11 Diet, Fat-Restricted/OR Diet/OR Diet, Protein-Restricted/OR Diet,
Carbohydrate-Restricted/OR Diet.mp. OR Diet, Reducing/OR
Diet Therapy/
255,985
12 Life Style/ 36,837
13 Health Education/ 48,625
14 Patient Education as Topic/ 63,238
15 Exercise.mp. OR Exercise/OR Exercise, Therapy/ 192,937
16 Health Promotion/ 43,967
17 Weight Loss/ 19,434
18 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 601,919
19 10 AND 18 3,769
20 LIMIT 19 TO ((female or humans or pregnancy) and (clinical trial,
all OR clinical trial, phase i OR clinical trial, phase ii OR clinical trial,
phase iii OR clinical trial, phase iv OR clinical trial OR controlled
clinical trial OR randomized controlled trial))
154
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Table 2 A summary of the studies that met the criteria of the systematic review on lifestyle interventions in overweight and obese pregnant women:
randomised trials
Author
(year)
Ethnic group/
Country
Participant/setting Sample size Intervention Outcome measure
(s)
Conclusion
Polley et al.
(2002) [32]
31% black and
61% white/
USA
Recruited before 20 weeks of pregnancy
(normal BMI > 19.5 to 24.9; overweight
BMI ≥ 25 to < 30 kg/m2)/Hospital based
120, including
49 overweight
59 in control
arm; 61 in
intervention
arm
Exercise and nutrition information (oral and
newsletter) Personalised graphs and
behavioural counselling.
Gestational weight
gain; gestational
diabetes; Caesarean
section; birthweight
No statistically significant reduction in
gestational weight, prevalence of
gestational diabetes, Caesarean
section, or large for gestational age
baby
Hui et al.
(2006) [33]
Predominantly
Caucasian/
Canada
Less than 26 weeks pregnant (community
based and antenatal clinics). All BMI
categories. Mean BMI of non-intervention
arm = 25.7 (SD = 6.3) and for
intervention arm = 23.4(SD = 3.9)
45
21 in non-
intervention
arm; 24 in
intervention
arm
Physical exercise (group-sessions home-
based exercise)
Individualized nutrition plans
Gestational weight
gain
No statistically significant reduction in
gestational weight gain
Wolff et al.,
2008 [30]
100%
Caucasian/
Denmark
Obese (BMI ≥ 30 kg/m2) women enrolled
at 15 weeks’ gestation
50 analysed
23 in control
arm; 27 in
intervention
arm
Intensive intervention with 10 one-hour
visits with a dietician at each antenatal visit,
dietary guidance provided
Gestational weight
gain; gestational
diabetes; Caesarean
section; birthweight
Statistically significant reduction in
gestational weight gain, no
statistically significant reduction in
prevalence of gestational diabetes or
Caesarean section, or birthweight
Jeffries et al.,
2009 [28]
> 90%
Caucasian/
Australia
Women at or below 14 weeks’ gestation.
All BMI categories included
286
138 in control
arm; 148 in
intervention
arm
Personalised weight measurement card
(based on Institute of Medicine guidelines).
Control had only single measurement at
enrolment
Gestational weight
gain
No statistically significant reduction in
gestational weight gain.
Ong et al.,
2009 [42]
Predominantly
Caucasian/
Australia
Pregnant obese women recruited at 18
weeks’ gestation
12
six in control
arm; six in
intervention
arm
Personalised 10 weeks of home-based
supervised exercise (three sessions per
week)
Maternal aerobic
fitness and
gestational diabetes
No statistically significant difference in
aerobic fitness or gestational diabetes
Barakat et
al., 2011 [41]
100%
Caucasian/
Spain
All BMI categories 160
80 in control
arm; 80 in
intervention
arm
Three group-based sessions per week, light
resistance and toning exercise from the
second trimester
Gestational weight
gain and
birthweight
No statistically significant difference in
gestational weight gain and birth
weight. Exercise intervention might
attenuate adverse consequences of
maternal BMI on newborn birth size
Asbee et al.,
2009 [27]
26% African
American/USA
Pregnant women recruited before 16
weeks’ gestation. All BMI categories
except those of BMI > 40 kg/m2
100
43 in control
arm; 53 in
intervention
arm
One session of dietetic counselling and
activity
Gestational weight
gain; pregnancy
outcome
Statistically significant reduction in
gestational weight gain. No effect on
pregnancy outcome
Thornton et
al., 2009 [29]
41% African
American/USA
Obese pregnant women (BMI ≥ 30 kg/
m2) recruited between 12 and 28 weeks’
gestation
257
randomised.
25 lost to
follow up. 116
in control
arm; 116 in
intervention
arm
Nutritional regime for gestational diabetes Gestational weight
gain; gestational
diabetes; Caesarean
section; pregnancy
outcome
Statistically significant reduction in
gestational weight gain, no
statistically significant reduction in
prevalence of gestational diabetes,
Caesarean section or birthweight
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Table 2 A summary of the studies that met the criteria of the systematic review on lifestyle interventions in overweight and obese pregnant women: rando-
mised trials (Continued)
Guelinckx et
al., 2010 [26]
100%
Caucasian/
Belgium
Obese (BMI > 30 kg/m2) women enrolled
at 15 weeks’ gestation.
195
randomised
85 analysed
65 in control
arm; 65 in
passive arm,
65 in
intervention
arm
Three arms: group sessions with a dietician;
written brochures; and standard care
Dietary and physical activity guidance
provided by dietician and in written
brochures
Nutritional habits;
gestational weight
gain; gestational
diabetes; Caesarean
section; birthweight
Improved nutritional habits; no
statistically significant reduction in
gestational weight gain, prevalence of
gestational diabetes, Caesarean
section or birthweight.
Phelan et
al., 2011 [34]
67% White/
USA
Pregnant women BMI between 19.8 and
40 kg/m2 recruited between 10 and 16
weeks’ gestation
401
randomised.
201 in non-
intervention
arm; 200 in
intervention
arm
Exercise and nutrition information (oral and
newsletter) Personalised graphs and
behavioural counselling
Gestational weight
gain; gestational
diabetes; Caesarean
section; pregnancy
outcome
Significant reduction in gestational
weight gain; no statistically significant
reduction in prevalence of gestational
diabetes, Caesarean section or
birthweight
Quinlivan et
al., 2011 [59]
73% white,
19% Asian/
Australia
Pregnant women: overweight (BMI 25 to
29.9 kg/m2) and obese (BMI ≥ 30 kg/m2)
132
randomised.
65 in non-
intervention
arm; 67 in
intervention
arm
Attended a study- specific antenatal clinic
providing continuity of care, weighing on
arrival, brief dietary intervention by food
technologist and psychological assessment
and intervention if indicated
Gestational weight
gain; gestational
diabetes;
birthweight
Statistically significant reduction in
gestational weight gain and
prevalence of gestational weight gain.
No statistically significant reduction in
birthweight.
Luoto et al.,
2011 [43]
Predominantly
white/Finland
Pregnant women at risk of gestational
diabetes. All BMI ranges
399 cluster
randomised.
219 in non-
intervention
arm; 180 in
intervention
arm
Attended a study-specific individual
antenatal lifestyle counselling clinic
including group exercise
Gestational
diabetes;
gestational weight
gain; birthweight
Statistically significant reduction in
birthweight and macrosomia but no
statistically significant difference in
gestational diabetes
Nascimento
et al., 2011
[44]
Predominantly
white/Brazil
Pregnant women of all BMI categories 82
randomised.
42 in non-
intervention
arm; 40 in
intervention
arm
Attended a group-based exercise under
supervision and received a home exercise
counselling
Gestational weight
gain; raised blood
pressure; perinatal
outcome
No statistically significant difference in
gestational weight gain in terms of
gestational weight gain, raised blood
pressure or perinatal outcome
BMI: body mass index; SD: standard deviation
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Table 3 Summary of the studies that met the criteria of the systematic review on lifestyle interventions in overweight and obese pregnant women: non-
randomised trials
Author
(year)
Ethnic group/
country
Participants/setting Sample size Intervention Outcome measure
(s)
Conclusion
Gray-
Donald et
al. (2000)
[38]
Native
Americans/
Canada
Recruited before the 26th week of
pregnancy, non-parallel recruitment of
control and intervention arms.
Mean BMI = 29.6 kg/m2 (SD = 6.45) in
non-intervention arm and mean BMI =
30.8 kg/m2 (SD = 6.85) in intervention
arm at baseline.
219
107 in non-
intervention
arm; 112 in
intervention
arm
Dietary and weight counselling
Exercise groups provided
Gestational weight
gain; gestational
diabetes;
Caesarean section;
birthweight;
postpartum weight
retention
No statistically significant difference in
gestational weight gain, prevalence of
gestational diabetes, Caesarean section or
large for gestational age baby
Olson et
al. (2004)
[51]
96% white/
USA
Recruited before third trimester.
Hospital and clinic setting
BMI range: 19.8 to 29 kg/m2
498
381 in non-
intervention
arm; 117 in
the
intervention
arm
Used the Institute of Medicine
recommended guidelines on weight gain;
‘health book’ used to record diet and
exercise and contained healthy eating and
exercise information
Gestational weight
gain; birthweight
No statistically significant reduction in
gestational weight gain or prevalence of
large for gestational age baby
Claesson
et al.
(2007)
[36]
Not stated.
Predominantly
Caucasian/
Sweden
Obese and registered at antenatal care
clinic.
BMI ≥ 30 kg/m2
348
193 in non-
intervention
arm; 155 in
intervention
arm
Nutritional habits interview, weekly
counselling and aqua aerobic sessions
Gestational weight
gain; Caesarean
section.
Statistically significant reduction in
gestational weight gain; no difference in
prevalence of Caesarean section
Kinnunen
et al.
(2007)
[37]
Over 90%
Caucasian/
Finland
First-time pregnant women who were
obese (BMI ≥ 30 kg/m2)
196
95 in non-
intervention
arm; 101 in
intervention
arm
Individual counselling at each antenatal
visits. Dietary guidance and optional activity
sessions.
Gestational weight
gain; diet change;
birthweight
No statistically significant reduction in
gestational weight gain or prevalence of
large for gestational age baby. Statistically
significant reduction in dietary glycaemic
load.
Shirazian
et al.,
2010 [39]
33% blacks;
67% Latino/
USA
Singleton obese (≥ 30 kg/m2) pregnant
women recruited in the first trimester.
Historical non-intervention group.
54
28 in non-
parallel
control arm;
28 in
intervention
arm)
One-to-one counselling; six structured
seminars on healthy living (healthy eating
and walking)
Gestational weight
gain; gestational
diabetes; Caesarean
section
Statistically significant reduction in
gestational weight gain; no difference in
prevalence of gestational diabetes
Mottola et
al., (2010)
[35]
Not stated/
Canada
Overweight (BMI ≥ 25 to 29.9 kg/m2)
and obese (BMI ≥ 30 kg/m2) pregnant
women recruited before 16 weeks’
gestation; historical non-intervention
group.
65 matched
non-parallel
control of 260
Individualised nutrition plan; exercise
consisted of walking (three to four times
per week, used pedometers)
Gestational weight
gain; Caesarean
section; birthweight;
peripartum weight
retention
Possible reduction in gestational weight
gain; no difference in prevalence of
Caesarean section or large for gestational
age baby; minimal effect on peripartum
weight retention
BMI: body mass index; SD: standard deviation.
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The pooled RCTs included a total of 1,228 partici-
pants and the pooled non-RCTs included 1,534 partici-
pants. Participants were predominantly white except in
the studies by Asbee et al. [27], Gray-Donald et al. [38]
and Hui et al. [33]. In the Asbee et al. study, the major-
ity were described as being of Hispanic ethnicity [27].
For all included RCTs, the control group received no
intervention or standard care. In the non-RCTs, most
used non-parallel controls [35,38,39,51] or controls from
another centre [36]. The outcomes investigated in the
trials were gestational weight gain, gestational diabetes,
Caesarean section delivery, large for gestational age baby
and birth weight.
Effects of the intervention on outcomes
Of the 19 controlled trials, 16 measured gestational
weight gain (10 randomised, 6 non-randomised); 8
recorded gestational diabetes (6 randomised, 2 non-ran-
domised); 10 recorded Caesarean delivery (6 rando-
mised, 4 non-randomised); 10 measured large for
gestational age (6 randomised, 4 non-randomised); and
7 measured birth weight (7 randomised). Meta-analyses
Table 4 Assessment of the quality of the included trials: non-randomised trials
Author (year) Population
representativeness
Adequacy of
sequence generation
Masking/
selection bias
Incomplete
outcome data
Contamination Sample
size
Grade of
quality
Gray-Donald et al.
(2000) [38]
Yes: Registered from
clinic
No No No No: non-parallel
control
219 Low
Olson et al. (2004)
[51]
Yes No No No No: non-parallel
control
560 Low
Claesson et al.
(2007) [36]
Yes: Registered from
clinic
No No Yes No: selected from
nearby city
315 Low
Kinnunen et al.
(2007) [37]
Yes No No No Yes 55 Low
Shirazian et al.,
(2010) [39]
Yes No No Yes No: non-parallel
control
28 Low
Mottola et al.,
(2010) [35]
Yes No No Yes No: non-parallel
control
65 Low
Table 5 Assessment quality of included trials: randomised trials
Author (year) Population
representativeness
Adequacy of
sequence generation
Masking/
selection bias
Intention
to treat
Incomplete
outcome data
Loss to
follow up
Sample
size
Grade of
quality
Polley et al. 2002
[32]
Yes Yes: No Not
reported
No Yes 120 Low
Hui et al. (2006)
[33]
Yes: from clinic Exact method not
described
No Not
reported
No Yes 52 Low
Wolff et al., 2008
[30]
Yes Yes: computer
generated
No Not
reported
Yes Yes 50 Low
Jeffries et al.,
2009 [28]
Yes Yes: Opaque envelope Yes Not
reported
Yes Yes 286 Low
Ong et al., 2009
[42]
Yes Exact method not
described
No Not
reported
No No 12 Low
Barakat et al.,
2011 [41]
Yes Yes Yes Yes Yes Yes 160 Medium
Asbee et al.
2009 [27]
Yes Yes No Not
reported
Yes No 100 Low
Thornton et al.,
2009 [29]
Yes Yes Yes Not
reported
Yes Yes 257 Medium
Guelinckx et al.,
2010 [26]
Not reported Randomised but not
reported how
Not reported Not
reported
Yes Not
reported
99 Low
Phelan et al.,
2011 [34]
Yes Yes: Opaque envelope Yes Yes Yes Yes 401 Medium,
Quinlivan et al.,
2011 [59]
Yes Yes: Opaque envelope Yes Yes Yes Yes 124 Medium
Luoto et al.,
2011 [43]
Yes Yes Yes Yes Yes Yes 399 Medium
Nascimento et
al., 2011 [44]
Yes Yes: Opaque envelope Yes Yes Yes Yes 82 Low
Oteng-Ntim et al. BMC Medicine 2012, 10:47
http://www.biomedcentral.com/1741-7015/10/47
Page 7 of 15
for the different outcomes are shown in Tables 6 and 7,
and Figures 2, 3, 4, 5, 6, 7, 8, 9 and 10.
Meta-analysis of RCTs showed that combined antena-
tal lifestyle, dietary and activity intervention restricts
gestational weight gain (Table 6 and Figure 2) and there
was a trend towards reduction in the prevalence of
gestational diabetes in overweight and obese women
(Table 6 and Figure 3). However, meta-analysis of non-
RCTs only showed weak evidence that lifestyle interven-
tion reduces gestational weight gain (Table 7 and Figure
7) and there was no evidence for a reduction in preva-
lence of gestational diabetes (Table 7 and Figure 8).
There was no robust evidence that lifestyle intervention
is associated with a lower prevalence of Caesarean deliv-
ery or macrosomia or any alteration in birth weight
(Tables 6 and 7, Figures 4,5, 6, 8, 9 and 10).
Intervention characteristics
The nature of the interventions varied widely between
studies and some of the key features of the interven-
tions are outlined in Tables 2 and 3. In summary, for
the six non-RCTs, three of the interventions comprised
individual and group or seminar components
[36,38,39,53], two were individual [35,52] and one was
Figure 1 Flow diagram of study selection.
Table 6 Effect estimates for randomised trials of lifestyle advice versus standard care
Outcome or subgroup Studies Participants Statistical method Effect estimate
Large for gestational age 6 1,008 Odds ratio (Fixed, 95% CI) 0.91 (0.62, 1.32)
Caesarean delivery 6 663 Odds ratio (Fixed, 95% CI) 0.96 (0.68, 1.36)
Gestational diabetes 6 1,017 Odds ratio (M-H, Fixed, 95% CI) 0.80 (0.58, 1.10)a
Gestational weight gain (kg) 10 1,228 Mean difference (Fixed, 95% CI) -2.21 (-2.86, -1.57)a
Birth weight (g) 7 1,133 Mean difference (Fixed, 95% CI) -56.64 (-120.15, 6.88)
aStatistically significant pooled estimates. CI: confidence interval
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unclear [51]. Of the 13 RCTs, one comprised individual
and group components [33], eight were individual
[27-30,32,34] and three were group-based [26]. Where
there were individual and group components, the latter
were usually physical activity sessions. All of the non-
RCTs included dietary and physical activity guidance, as
did the majority of the randomised studies. Exceptions
were two studies which included only nutritional gui-
dance [29,30] and one which included guidelines about
weight gain and weight monitoring only [28]. The
majority of studies included dietary or physical activity
guidance, with one of the non-RCTs [35] and three of
the RCTs [29,32-34] specifying that guidance was
personalised.
Table 7 Effect estimates for non-randomised trials of lifestyle advice versus standard care
Outcome or subgroup Studies Participants Statistical method Effect estimate
Large for gestational age 4 1,199 Odds ratio (Fixed, 95% CI) 0.85 (0.63, 1.16)
Caesarean delivery 4 1,246 Odds ratio (Fixed, 95% CI) 1.13 (0.78, 1.64)
Gestational diabetes 2 233 Odds ratio (Fixed, 95% CI) 1.51 (0.72, 3.16)
Gestational weight gain (kg) 6 1,534 Mean difference (Fixed, 95% CI) -0.42 (-1.03, 0.19)
CI: confidence interval
Study or Subgroup
Polley 2002
Barakat 2009
Thornton 2009
Ong 2009
Jeffries 2009
Guelinckx 2010
Phelan 2011
Quinlivan 2011
Luoto 2011
Nascimento 2011
Total (95% CI)
Heterogeneity: Chi² = 110.98, df = 9 (P < 0.00001); I² = 92%
Test for overall effect: Z = 6.69 (P < 0.00001)
Mean
13.6
10.9
4.989
3.7
9.5
9.8
14.7
7
13.8
10.3
SD
7.2
4.9
6.785
3.4
5.17
7.6
6.9
5.16
5.8
5
Total
27
14
116
6
25
42
87
63
216
39
635
Mean
10.1
12.3
14.06
5.2
8.2
10.6
15.1
13.8
14.2
11.5
SD
6.2
3.9
7.39
1.3
3.02
6.9
7.5
5.23
5.1
7.4
Total
22
14
116
6
21
43
90
61
179
41
593
Weight
3.0%
3.9%
12.6%
5.0%
7.3%
4.4%
9.3%
12.6%
36.4%
5.5%
100.0%
IV, Fixed, 95% CI
3.50 [-0.25, 7.25]
-1.40 [-4.68, 1.88]
-9.07 [-10.90, -7.25]
-1.50 [-4.41, 1.41]
1.30 [-1.10, 3.70]
-0.80 [-3.89, 2.29]
-0.40 [-2.52, 1.72]
-6.80 [-8.63, -4.97]
-0.40 [-1.48, 0.68]
-1.20 [-3.96, 1.56]
-2.21 [-2.86, -1.57]
Year
2002
2009
2009
2009
2009
2010
2011
2011
2011
2011
Experimental Control Mean Difference Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Favours experimental Favours control
Figure 2 Forest plot of randomised trials investigating the effect of lifestyle advice versus standard care on gestational weight gain
(kg).
Study or Subgroup
Polley 2002
Wolff 2008
Thornton 2009
Luoto 2011
Phelan 2011
Quinlivan 2011
Total (95% CI)
Total events
Heterogeneity: Chi² = 13.04, df = 5 (P = 0.02); I² = 62%
Test for overall effect: Z = 1.38 (P = 0.17)
Events
2
0
11
73
11
4
101
Total
27
23
116
216
81
63
526
Events
1
3
19
59
7
17
106
Total
22
27
116
179
86
61
491
Weight
1.2%
3.7%
20.0%
49.6%
6.8%
18.8%
100.0%
M-H, Fixed, 95% CI
1.68 [0.14, 19.85]
0.15 [0.01, 3.04]
0.53 [0.24, 1.18]
1.04 [0.68, 1.58]
1.77 [0.65, 4.82]
0.18 [0.06, 0.56]
0.80 [0.58, 1.10]
Year
2002
2008
2009
2011
2011
2011
Experimental Control Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.05 0.2 1 5 20
Favours experimental Favours control
Figure 3 Forest plot of randomised trials investigating the effect of lifestyle advice versus standard care on risk of gestational
diabetes.
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Study or Subgroup
Polley 2002
Wolff 2008
Thornton 2009
Guelinckx 2010
Phelan 2011
Nascimento 2011
Total (95% CI)
Total events
Heterogeneity: Chi² = 7.35, df = 5 (P = 0.20); I² = 32%
Test for overall effect: Z = 0.23 (P = 0.82)
Events
2
2
91
11
33
25
164
Total
27
23
116
42
81
39
328
Events
6
3
83
7
42
29
170
Total
22
27
116
43
86
41
335
Weight
9.3%
3.8%
27.1%
7.7%
36.6%
15.4%
100.0%
M-H, Fixed, 95% CI
0.21 [0.04, 1.19]
0.76 [0.12, 5.01]
1.45 [0.80, 2.63]
1.82 [0.63, 5.28]
0.72 [0.39, 1.33]
0.74 [0.29, 1.89]
0.96 [0.68, 1.36]
Year
2002
2008
2009
2010
2011
2011
Experimental Control Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.1 0.2 0.5 1 2 5 10
Favours experimental Favours control
Figure 4 Forest plot of randomised trials investigating the effect of lifestyle advice versus standard care on risk of Caesarean delivery.
Study or Subgroup
Polley 2002
Thornton 2009
Guelinckx 2010
Phelan 2011
Luoto 2011
Nascimento 2011
Total (95% CI)
Total events
Heterogeneity: Chi² = 5.88, df = 4 (P = 0.21); I² = 32%
Test for overall effect: Z = 0.51 (P = 0.61)
Events
0
9
5
14
26
8
62
Total
27
116
42
81
216
39
521
Events
0
4
3
14
34
8
63
Total
22
116
43
86
179
41
487
Weight
6.5%
4.6%
19.9%
57.9%
11.0%
100.0%
M-H, Fixed, 95% CI
Not estimable
2.36 [0.70, 7.88]
1.80 [0.40, 8.07]
1.07 [0.48, 2.42]
0.58 [0.34, 1.02]
1.06 [0.36, 3.18]
0.91 [0.62, 1.32]
Year
2002
2009
2010
2011
2011
2011
Experimental Control Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Favours experimental Favours control
Figure 5 Forest plot of randomised trials investigating the effect of lifestyle advice versus standard care on risk of large for
gestational age baby.
Study or Subgroup
Wolff 2008
Thornton 2009
Guelinckx 2010
Luoto 2011
Quinlivan 2011
Nascimento 2011
Phelan 2011
Total (95% CI)
Heterogeneity: Chi² = 6.41, df = 6 (P = 0.38); I² = 6%
Test for overall effect: Z = 1.75 (P = 0.08)
Mean
3,757
3,526
3,492
3,532
3,500
3,267
3,430
SD
617
608
468
514
556
700
650
Total
23
116
42
216
63
39
81
580
Mean
3,895
3,586
3,419
3,659
3,400
3,228
3,442
SD
485
560
425
455
781
591
629
Total
27
116
43
179
61
41
86
553
Weight
4.2%
17.8%
11.2%
44.1%
7.0%
5.0%
10.7%
100.0%
IV, Fixed, 95% CI
-138.00 [-449.53, 173.53]
-60.00 [-210.42, 90.42]
73.00 [-117.18, 263.18]
-127.00 [-222.61, -31.39]
100.00 [-139.29, 339.29]
39.00 [-245.59, 323.59]
-12.00 [-206.19, 182.19]
-56.64 [-120.15, 6.88]
Year
2008
2009
2010
2011
2011
2011
2011
Experimental Control Mean Difference Mean Difference
IV, Fixed, 95% CI
-200 -100 0 100 200
Favours experimental Favours control
Figure 6 Forest plot of randomised trials investigating the effect of lifestyle advice versus standard care on birthweight.
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Discussion
Summary of main findings
Antenatal lifestyle, dietary and activity advice for over-
weight and obese pregnant women restricts maternal
weight gain during pregnancy and lowers the prevalence
of gestational diabetes in women who are overweight or
obese. However, the quality of the study designs was
generally poor. The reduction in gestational weight gain
was observed to be statistically significant in the meta-
analysis of randomised trials (10 RCTs; n = 1,228; -2.21
kg (95% CI, -2.86 to -1.57 kg)) but non-significant in
the meta-analysis of non-randomised trials (six non-
RCTs; n = 1,534). No effects of antenatal lifestyle inter-
ventions were identified in obese and overweight preg-
nant women in relation to Caesarean delivery, large for
gestational age, birth weight and macrosomia (> 4 kg).
Interpretation
There is evidence to suggest antenatal lifestyle interven-
tions may restrict gestational weight gain and a trend
Study or Subgroup
Gray-Donald 2000
Olson 2004
Kinnunen 2007
Mottola 2010
Total (95% CI)
Total events
Heterogeneity: Chi² = 5.20, df = 3 (P = 0.16); I² = 42%
Test for overall effect: Z = 1.02 (P = 0.31)
Events
37
32
0
12
81
Total
106
179
49
65
399
Events
31
83
8
51
173
Total
103
381
56
260
800
Weight
23.1%
49.2%
8.9%
18.8%
100.0%
M-H, Fixed, 95% CI
1.25 [0.70, 2.23]
0.78 [0.50, 1.23]
0.06 [0.00, 1.03]
0.93 [0.46, 1.86]
0.85 [0.63, 1.16]
Year
2000
2004
2007
2010
Lifestyle advice Standard care Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.5 0.7 1 1.5 2
Favours experimental Favours control
Figure 7 Forest plot of non-randomised trials investigating the effect of lifestyle advice versus standard care on risk of large for
gestational age baby.
Study or Subgroup
Gray-Donald 2000
Claesson 2008
Shirazian 2009
Mottola 2010
Total (95% CI)
Total events
Heterogeneity: Chi² = 1.15, df = 3 (P = 0.76); I² = 0%
Test for overall effect: Z = 0.64 (P = 0.52)
Events
15
35
10
3
63
Total
106
295
21
65
487
Events
13
39
7
18
77
Total
103
376
20
260
759
Weight
21.7%
57.9%
7.2%
13.2%
100.0%
M-H, Fixed, 95% CI
1.14 [0.51, 2.53]
1.16 [0.72, 1.89]
1.69 [0.48, 5.93]
0.65 [0.19, 2.28]
1.13 [0.78, 1.64]
Year
2000
2008
2009
2010
Lifestyle advice Standard care Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Favours experimental Favours control
Figure 8 Forest plot of non-randomised trials investigating the effect of lifestyle advice versus standard care on risk of Caesarean
section.
Study or Subgroup
Gray-Donald 2000
Shirazian 2009
Total (95% CI)
Total events
Heterogeneity: Chi² = 0.01, df = 1 (P = 0.93); I² = 0%
Test for overall effect: Z = 1.10 (P = 0.27)
Events
15
6
21
Total
99
21
120
Events
10
4
14
Total
93
20
113
Weight
74.9%
25.1%
100.0%
M-H, Fixed, 95% CI
1.48 [0.63, 3.49]
1.60 [0.38, 6.81]
1.51 [0.72, 3.16]
Year
2000
2009
Lifestyle advice Standard care Odds Ratio Odds Ratio
M-H, Fixed, 95% CI
0.2 0.5 1 2 5
Favours experimental Favours control
Figure 9 Forest plot of non-randomised trials investigating the effect of lifestyle advice versus standard care on risk of gestational
diabetes.
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towards a reduced prevalence of gestational diabetes, but
there was no statistical effect on other important clinical
outcomes, possibly due to inadequate power of the com-
bined sample size. The effect on restricted weight gain
and gestational diabetes was not consistent across all the
trial populations and therefore cannot be generalised.
There was also wide variation in the types of interven-
tions evaluated in the studies. The majority were indivi-
dual-based and most provided generic guidance
comprising mainly dietary and physical activity informa-
tion, with few tailoring guidelines. There was consider-
able heterogeneity in intervention design and no obvious
patterns between intervention type and study outcomes.
For the gestational weight gain and gestational diabetes
outcomes, both the successful and non-successful studies
included those which were personalised, combined physi-
cal activity and dietary guidance and were individual-
based. Moreover, degrees of weight gain restriction
achieved were modest overall. It is even harder to make
conclusions regarding the specific behaviour change stra-
tegies included (for example, monitoring and goal set-
ting) or theoretical basis of interventions since these were
typically poorly reported.
Identifying specific components of successful interven-
tions aids understanding of how interventions are having
an effect and clear reporting of intervention design allows
for easier replication [54]. Previous reviews have attempted
to make conclusions regarding specific effective compo-
nents of interventions. Suggestions that weight monitoring
and setting weight goals could be useful [46] and also mon-
itoring along with education counselling and physical activ-
ity sessions [51,55] have been made. Another review
suggested that interventions should be based on the Theory
of Planned Behaviour, but the rationale for using this
model over others in this population was unclear [56].
None of these reviews examined intervention components
systematically. A more recent review by Gardner et al.
assessed interventions targeting gestational weight gain
from a psychological perspective and specifically examined
intervention content and delivery methods [57]. This
review comprised 10 controlled trials, all included in the
current review; only two of the studies reported basing
interventions on theory and the studies used, on average,
five behaviour change strategies (self-monitoring, feedback
provision and setting behavioural goals were the most com-
mon), but no conclusions could be drawn as to their contri-
bution to study outcomes. Broadly consistent with this
were the four studies in the current review which were not
included in the review by Gardner et al. [57]. Their review
questioned the evidence supporting the benefits of weight
monitoring, but tentatively suggested that information pro-
vision had been underused and that it might be of benefit
to have a narrower focus of intervention targets [57].
Comparison with other systematic reviews and strengths
Our study adds to a growing body of evidence that aims
to evaluate lifestyle intervention as a means to minimise
the adverse outcome associated with obesity in preg-
nancy. In comparison to other published reviews
[45,46,56], we have adopted an original approach by
broadening the literature source (multiple data sources,
no language restriction), focusing on relevant clinical
outcomes (such as Caesarean section, gestational dia-
betes, macrosomia), and improving our sensitivity by
meta-analysing both RCTs and non-RCTs. Furthermore,
to minimise bias, the review methodology was registered
a priori (Prospero number CRD420111122 http://www.
crd.york.ac.uk/PROSPERO). We therefore believe our
review provides a comprehensive and reliable analysis of
the current evidence and for the first time highlights
that lifestyle intervention in pregnancy may reduce the
prevalence of gestational diabetes.
Limitations of this systematic review
The evidence summarised in this work comes from
available studies of which most are of low quality, with
Study or Subgroup
Gray-Donald 2000
Olson 2004
Kinnunen 2007
Claesson 2008
Shirazian 2009
Mottola 2010
Total (95% CI)
Heterogeneity: Chi² = 28.55, df = 4 (P < 0.00001); I² = 86%
Test for overall effect: Z = 1.35 (P = 0.18)
Mean
12
14.8
14.6
8.7
8.06
12
SD
6.4
4.68
5.4
5.51
7.27
5.7
Total
104
179
48
143
21
65
560
Mean
13.2
14.1
14.3
11.3
15.42
0
SD
8.3
4.51
4.1
5.8
7.52
0
Total
96
381
56
161
20
260
974
Weight
8.8%
55.5%
10.7%
23.2%
1.8%
100.0%
IV, Fixed, 95% CI
-1.20 [-3.27, 0.87]
0.70 [-0.12, 1.52]
0.30 [-1.57, 2.17]
-2.60 [-3.87, -1.33]
-7.36 [-11.89, -2.83]
Not estimable
-0.42 [-1.03, 0.19]
Year
2000
2004
2007
2008
2009
2010
Lifestyle intervention Control Mean Difference Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
Favours experimental Favours control
Figure 10 Forest plot of non-randomised trials investigating the effect of lifestyle advice versus standard care on gestational weight
gain (kg).
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only four studies fulfilling a medium quality score.
Hence, the evidence base is weak and calls for more
robust studies. Our trial population is relatively small,
the intensity and duration of the interventions of trials
varied and trials were predominantly USA in origin; a
phenomenon common to many public health reviews,
especially on obesity. Although our focus was on
antenatal lifestyle intervention for obese and overweight
pregnant women, our search yielded some studies that
contained a mixed group of obese and normal weight
women and we excluded all the non-obese participants
from our analysis. Still, this may lead to inconsistencies
in measuring the effect of the intervention as well as
under- or overestimating the treatment effect. Further-
more, even though our search was systematic and rigor-
ous, we could have missed eligible studies inadvertently.
Conclusions
This review reveals that lifestyle interventions for obese
and overweight women during pregnancy restrict gesta-
tional weight gain and a trend was evident towards
reducing the prevalence of gestational diabetes. How-
ever, the quality of the published studies is mainly poor.
This then highlights a paradox. At a time when solu-
tions to address adverse outcome associated with mater-
nal overweight and obesity are identified as a public
health priority, we find that most of the research evi-
dence lacks robustness to inform future evidence-based
lifestyle interventions for obese pregnant women. There
is thus a research gap regarding the effectiveness of life-
style intervention in pregnancy. It is unlikely that further
meta-analysis will help to refine the quality of evidence
because studies demonstrated significant heterogeneity
in relation to demography, outcome measurement, fol-
low-up and degree of intervention. Hence, we conclude
that there is the need for a well-designed large-scale
prospective trial which examines combined antenatal
lifestyle interventions in obese pregnant women that is
suitably powered and incorporates robust methodology
in accordance with standards set by Medical Research
Council’s framework for evaluating complex interven-
tions [58]. There are two such studies which are cur-
rently ongoing called LIMIT (ACTRN 12607000161426)
and UPBEAT (ISRCTN89971375). Both of these studies
are appropriately powered to show convincingly whether
lifestyle intervention is most likely to improve pregnancy
outcome or not.
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